Everyone's Talking About the SpaceX IPO. Why I Think You Should Avoid It, and What to Buy Instead.

SpaceX has reportedly filed confidentially for an IPO and is said to be targeting a $1.75 trillion valuation while aiming to raise $75 billion, implying an estimated 87x price-to-sales multiple on about $20 billion of 2026 revenue. The article argues the valuation is stretched and warns retail investors against chasing the stock, favoring diversified space-themed ETFs such as ARKX, PPA, and XAR instead. The piece is primarily opinion-driven commentary rather than new fundamental disclosure, so near-term market impact is limited.

Analysis

The immediate market reaction is less about SpaceX itself and more about the valuation gravity it exerts on the whole private-space complex. A $1.75T print would reset reference points for late-stage venture marks, which is bullish for adjacent private names and public proxies in the near term, but it also raises the bar so high that any post-listing normalization could compress multiples across the theme. The second-order effect is a wider capital-formation window: suppliers, launch-adjacent hardware, satellite communications, and defense primes may see incremental investor interest as the market searches for “cheaper space exposure” with actual liquidity.

The key risk is that the IPO becomes a sentiment event rather than a fundamentals event. If the deal prices at a premium to already-optimistic 2026 revenue assumptions, the stock can trade well on scarcity for days or weeks, but the unwind risk over the following 3-6 months is material if the company is forced to demonstrate margin durability, launch cadence, and Starlink monetization without the private-market opacity. Any sign of slower subscriber growth, higher capex intensity, or xAI integration dilution would hit the multiple first, not the top line.

The consensus is underestimating how much this could benefit the public comparables even if the IPO itself is uninvestable. Rocket lab / satellite / defense names become the “good enough” trade for institutions that want theme exposure without paying venture-style prices, and the more speculative legs of the basket should outperform on the rumor phase. Conversely, the most crowded long in the ecosystem may end up being the headline itself; if the IPO is delayed, downsized, or price-discovered lower than marketed, the disappointment trade could be sharper than the initial euphoria because positioning is likely one-way.

Key Decisions for Investors

• Long XAR or PPA vs short broader market cyclicals for 1-3 months: best risk-adjusted way to own the space/defense re-rating while avoiding single-name IPO risk; expect low-double-digit upside if the theme stays hot.
• Buy PL on weakness over the next 2-4 weeks as a secondary beneficiary of the 'public space beta' bid; asymmetric upside if retail/fund flows rotate into liquid space proxies ahead of any SpaceX listing.
• Initiate a tactical long AVGO / short TSLA pair for 1-2 months if SpaceX hype spills over into Musk-linked momentum: AVGO captures AI/infra demand with cleaner fundamentals, while TSLA remains more vulnerable to sentiment reversal.
• For more aggressive exposure, use ACHR as a call-option proxy on speculative aerospace enthusiasm, but size small; upside can overshoot in a risk-on tape, while downside is high if the IPO narrative fades.
• Avoid chasing any direct SpaceX-linked enthusiasm until after pricing terms are clear; if the implied multiple stays above 70-80x sales-equivalent on forward revenue, the better trade is to fade post-IPO strength with puts or a short after the first lock-up/range expansion.